Henry Schein, Inc. (HSIC) registered adjusted earnings per share (EPS) of $1.22 in the third quarter of 2024, down 7.6% from the year-ago figure. However, the metric exceeded the Zacks Consensus Estimate by 5.2%.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the earnings announcement, HSIC stock rose 0.03% at pre-market trading today.HSIC’s Q3 Revenues in DetailHenry Schein reported net sales of $3.17 billion, up a marginal 0.4% year over year. The metric lagged the Zacks C ...

Henry Schein (HSIC) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.32 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 5.17%. A quarter ago, it was expected that this health care products maker would post earnings of $1.22 per share when it actually produced earnings of $1.23, delivering a surprise of 0.82%.Over the last four quarters ...

PRESS RELEASE FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND INCREASES 2024 FINANCIAL GUIDANCE ● Third-quarter 2024 GAAP diluted EPS of $0.78 and non-GAAP dilutedEPS of $1.22 ● Operating cash flow of $151 million for the third quarter of 2024; year-to-date operating cash flow of $644 million, up $112 million compared with year-to-date 2023 ● Increases 2024 full-year non-GAAP EPS guidance to $4.74 to $4.82 from $4.70 to $4.82 MELVILLE, N.Y., November 5, 2024 – Henry Schei ...

Analysts on Wall Street project that Henry Schein (HSIC) will announce quarterly earnings of $1.16 per share in its forthcoming report, representing a decline of 12.1% year over year. Revenues are projected to reach $3.24 billion, increasing 2.5% from the same quarter last year.The consensus EPS estimate for the quarter has undergone an upward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates ...

The market expects Henry Schein (HSIC) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be rele ...

Henry Schein, Inc. (HSIC) is scheduled to release third-quarter 2024 results on Nov. 5, before the opening bell.In the last reported quarter, the company posted adjusted earnings per share (EPS) of $1.23, which beat the Zacks Consensus Estimate by 0.8%. In the trailing four quarters, Henry Schein’s earnings met estimates once, surpassed twice and missed in the other, delivering an average negative surprise of 1.56%.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.HSIC’s Q3 EstimatesThe ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Henry Schein (HSIC) . This company, which is in the Zacks Medical - Dental Supplies industry, shows potential for another earnings beat. This health care products maker has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the pa ...

Henry Schein (HSIC) is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic uncertainties are concerns for Henry Schein. The stock carries a Zacks Rank #3 (Hold) currently. Factors Driving HSIC Stock Henry Schein's revenue growth has been consistently supported by niche acquisitions and partnerships. Its robust acquisition strategy helps it to pursue targets that provide access to additional product lines. In July, Henry Schein acquired 100% of ABC Dental ...

Henry Schein's (HSIC) dental software business, Henry Schein One, has introduced two new tools — Eligibility Essentials and Eligibility Pro — to simplify the insurance eligibility process for dental practices. Currently available for Dentrix and Dentrix Ascend cloud-based practice management solutions, the new tools are designed to help foster trust between dental practices and patients by reducing insurance-related surprises. Henry Schein One is the largest component in the company's Technology and value-a ...

A month has gone by since the last earnings report for Henry Schein (HSIC) . Shares have added about 5.6% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Henry Schein due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Henry Schein (HSIC) , has gained 8.6% over the ...